Glass House Brands (GLAS) Equity Income (2022 - 2025)
Glass House Brands' (GLAS) quarterly Equity Income came in at -$44000.0 in Q2 2025, down 146.81% year-on-year from $94000.0 in Q2 2024, and up 2.22% on a QoQ basis from -$45000.0 in Q3 2024.
Glass House Brands (GLAS) Equity Income (2022 - 2025) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Equity Income data on file, last reported at -$44000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -44,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Sep 30, 2023 | -91,248.00 |
| Jun 30, 2023 | -35.81 Bn |
| Mar 31, 2023 | 2.26 Mn |
| Sep 30, 2022 | 871,329.00 |
| Jun 30, 2022 | 73.00 Bn |